Abstract
Introduction. The introduction of modern technologies of conformal external beam radiotherapy (EBRT) into clinical practice for the treatment of prostate cancer requires proper quality assurance measures as well as a careful analysis of both the efficacy and toxicity data of treatments. The purpose of this study was to inves- tigate tolerance and the immediate efficacy of conformal dose-escalated EBRT during hormono-radiotherapy for prostate cancer. material and methods. The study involved 156 prostate cancer patients treated with EBRT. Among them, 30 patients received a total dose of 70 Gy, and in 126 patients the total dose was esca- lated to 72-76 Gy (median total dose - 74.0 Gy). Fifty-nine patients received intensity modulated radiation therapy. Results. The prescribed course of treatment was completed in all the patients with prostate cancer. Acute radiation-induced bladder reactions (RTOG) were observed in 50 (32.1 %) patients, of whom 48 (30.8 %) experienced grade I reactions, and 2 (1.3 %) experienced grade II reactions. Eighteen (11.5 %) patients had radiation-induced rectum reactions, not above grade I. The development of grade II dysuric phenomena necessitated treatment interruption only in two patients. Of 9 (5.8 %) patients who had late bladder complica- tions (RTOG/EORTC), 8 (5.1 %) patients developed grade I complications, and one (0.6 %) patient developed grade II complications. Of 11 (7.1 %) patients who had rectum complications, 8 (5.1 %) patients developed grade I complications, and 3 (1.9 %) patients developed grade II complications. No patients experienced the increase in toxicity of treatment during dose escalation up to a total dose exceeding 70 Gy. During the follow-up period, only one patient developed recurrent disease. Conclusion. The results of our study suggest acceptable levels of toxicity following a continuous course of dose-escalated EBRT given in conjunction with hormono-radiotherapy to prostate cancer patients. Further studies are needed to investigate the impact of dose escalation on long-term outcomes as well as the rate and grade of late complications.
Highlights
The introduction of modern technologies of conformal external beam radiotherapy (EBRT) into clinical practice for the treatment of prostate cancer requires proper quality assurance measures as well as a careful analysis of both the efficacy and toxicity data of treatments
The study involved 156 prostate cancer patients treated with EBRT
The prescribed course of treatment was completed in all the patients with prostate cancer
Summary
Внедрение современных технологий конформной дистанционной лучевой терапии (ДЛТ) в практику лечения больных раком предстательной железы (РПЖ) требует обеспечения гарантии качества лечения, анализа его эффективности и токсичности. Целью исследования явилось изучение переносимости и непосредственной эффективности конформной ДЛТ с эскалацией суммарной очаговой дозы при гормонолучевом лечении РПЖ. Поздние осложнения (RTOG/EORTC) со стороны мочевого пузыря отмечены у 9 (5,8 %) больных, в том числе I степени – у 8 (5,1 %) пациентов, II – у 1 (0,6 %) больного. Осложнения со стороны прямой кишки наблюдали у 11 (7,1 %) пациентов, при этом I и II степени тяжести у 8 (5,1 %) и 3 (1,9 %) больных соответственно. Дистанционная лучевая терапия (ДЛТ) за длительный период своего развития стала одним из основных методов лечения РПЖ, но особенно в последнее десятилетие наблюдается значительный прогресс этого метода, в связи с чем технологии лучевой терапии вышли на качественно новый уровень. Появляется реальная возможность подведения высокой дозы в объём мишени, что увеличивает шанс достижения локального контроля и способствует улучшению выживаемости больных РПЖ
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.